Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.040 Biomarker Testing for Autoimmune Rheumatic DiseasePayerPolicy · PREMERA-15-01-040-BIOMARKER-TESTING-FOR-AUTOIMMUNE-RHEUMATIC-DISEASE-42A04F19FA | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.030 Diagnostic Testing of Iron Homeostasis and MetabolismPayerPolicy · PREMERA-15-01-030-DIAGNOSTIC-TESTING-OF-IRON-HOMEOSTASIS-AND-METABOL-1B769CB159 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.017 (effective September 4, 2026) TestosteronePayerPolicy · PREMERA-15-01-017-EFFECTIVE-SEPTEMBER-4-2026-TESTOSTERONE-5E9E0C317C | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.009 Metabolite Markers of Thiopurines TestingPayerPolicy · PREMERA-15-01-009-METABOLITE-MARKERS-OF-THIOPURINES-TESTING-D9C966566E | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 9.02.503 Computerized Diagnostic Imaging for Complex MaxillofacialPayerPolicy · PREMERA-9-02-503-COMPUTERIZED-DIAGNOSTIC-IMAGING-FOR-COMPLEX-MAXILLO-594097547F | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 9.02.502 PeriodonticsPayerPolicy · PREMERA-9-02-502-PERIODONTICS-0ACF98C5AF | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 8.01.502 Home Nutritional SupportPayerPolicy · PREMERA-8-01-502-HOME-NUTRITIONAL-SUPPORT-18D2C7DF09 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 3.01.521 Psychiatric and Other Specified Evaluations in InpatientPayerPolicy · PREMERA-3-01-521-PSYCHIATRIC-AND-OTHER-SPECIFIED-EVALUATIONS-IN-INPA-0F68615802 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.046 Prescription Medication and Illicit Drug Testing inPayerPolicy · PREMERA-15-01-046-PRESCRIPTION-MEDICATION-AND-ILLICIT-DRUG-TESTING-I-18B5890626 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.042 Serum Tumor Markers for MalignanciesPayerPolicy · PREMERA-15-01-042-SERUM-TUMOR-MARKERS-FOR-MALIGNANCIES-FE9741B7A1 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.023 Serum Testing for Evidence of Mild Traumatic BrainPayerPolicy · PREMERA-15-01-023-SERUM-TESTING-FOR-EVIDENCE-OF-MILD-TRAUMATIC-BRAIN-075AF93A75 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 11.01.522 Skilled Hourly Nursing Care in the HomePayerPolicy · PREMERA-11-01-522-SKILLED-HOURLY-NURSING-CARE-IN-THE-HOME-B52ED72F19 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 10.01.517 Non-covered Services and ProceduresPayerPolicy · PREMERA-10-01-517-NON-COVERED-SERVICES-AND-PROCEDURES-AC2E479C95 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.041 Intracellular Micronutrient AnalysisPayerPolicy · PREMERA-15-01-041-INTRACELLULAR-MICRONUTRIENT-ANALYSIS-AA73FBBBFA | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.028 Salivary Hormone TestingPayerPolicy · PREMERA-15-01-028-SALIVARY-HORMONE-TESTING-2837265873 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.019 General Inflammation TestingPayerPolicy · PREMERA-15-01-019-GENERAL-INFLAMMATION-TESTING-578DA87C58 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 10.01.518 Clinical TrialsPayerPolicy · PREMERA-10-01-518-CLINICAL-TRIALS-BBA07850A9 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.640 Pharmacologic Treatment of Sickle Cell DiseasePayerPolicy · PREMERA-5-01-640-PHARMACOLOGIC-TREATMENT-OF-SICKLE-CELL-DISEASE-A3F25647BD | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.651 Pharmacologic Treatment of Parkinson's DiseasePayerPolicy · PREMERA-5-01-651-PHARMACOLOGIC-TREATMENT-OF-PARKINSON-S-DISEASE-25C7999838 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.630 Intravenous Iron Replacement ProductsPayerPolicy · PREMERA-5-01-630-INTRAVENOUS-IRON-REPLACEMENT-PRODUCTS-7AF3292024 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.615 Pharmacologic Treatment of Chronic Non-Infectious LiverPayerPolicy · PREMERA-5-01-615-PHARMACOLOGIC-TREATMENT-OF-CHRONIC-NON-INFECTIOUS-L-8DE2C4DD28 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.627 Thymic Stromal Lymphopoietin (TSLP) InhibitorsPayerPolicy · PREMERA-5-01-627-THYMIC-STROMAL-LYMPHOPOIETIN-TSLP-INHIBITORS-9CFC403829 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.574 Pharmacotherapy of Spinal Muscular Atrophy (SMA)PayerPolicy · PREMERA-5-01-574-PHARMACOTHERAPY-OF-SPINAL-MUSCULAR-ATROPHY-SMA-FA6367627D | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.037 Onychomycosis TestingPayerPolicy · PREMERA-15-01-037-ONYCHOMYCOSIS-TESTING-88DF82C9BF | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.032 Helicobacter pylori TestingPayerPolicy · PREMERA-15-01-032-HELICOBACTER-PYLORI-TESTING-D1B37BEA07 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.031 Celiac Disease TestingPayerPolicy · PREMERA-15-01-031-CELIAC-DISEASE-TESTING-78DA5EAF2F | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.024 Folate TestingPayerPolicy · PREMERA-15-01-024-FOLATE-TESTING-3CA7F8ACDF | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.008 Lyme Disease TestingPayerPolicy · PREMERA-15-01-008-LYME-DISEASE-TESTING-30AEDC89E0 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 10.01.523 Preventive CarePayerPolicy · PREMERA-10-01-523-PREVENTIVE-CARE-FF79966A44 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.002 Flow CytometryPayerPolicy · PREMERA-15-01-002-FLOW-CYTOMETRY-A452ABFDF8 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.638 Omisirge (Omidubicel)PayerPolicy · PREMERA-5-01-638-OMISIRGE-OMIDUBICEL-B8619362D6 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.017 TestosteronePayerPolicy · PREMERA-15-01-017-TESTOSTERONE-663DC73CE4 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.005 ImmunohistochemistryPayerPolicy · PREMERA-15-01-005-IMMUNOHISTOCHEMISTRY-7117977AEE | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 7.01.180 Balloon Spacers for Treatment of Irreparable RotatorPayerPolicy · PREMERA-7-01-180-BALLOON-SPACERS-FOR-TREATMENT-OF-IRREPARABLE-ROTATO-9A855B85C4 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.631 Pharmacologic Treatment of Clostridioides DifficilePayerPolicy · PREMERA-5-01-631-PHARMACOLOGIC-TREATMENT-OF-CLOSTRIDIOIDES-DIFFICILE-0EF39A6C5B | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.581 Pharmacologic Treatment of HemophiliaPayerPolicy · PREMERA-5-01-581-PHARMACOLOGIC-TREATMENT-OF-HEMOPHILIA-886051A91A | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 1.01.520 Hospital Beds and AccessoriesPayerPolicy · PREMERA-1-01-520-HOSPITAL-BEDS-AND-ACCESSORIES-4C2A5B2F66 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.591 Immune Checkpoint InhibitorsPayerPolicy · PREMERA-5-01-591-IMMUNE-CHECKPOINT-INHIBITORS-50432CDF25 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.552 Hetlioz (tasimelteon)PayerPolicy · PREMERA-5-01-552-HETLIOZ-TASIMELTEON-9B4D006ED1 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 15.01.013 Serum Testing for Hepatic Fibrosis in the EvaluationPayerPolicy · PREMERA-15-01-013-SERUM-TESTING-FOR-HEPATIC-FIBROSIS-IN-THE-EVALUATI-92901AB735 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.582 Antibody-Drug ConjugatesPayerPolicy · PREMERA-5-01-582-ANTIBODY-DRUG-CONJUGATES-E516B0A0DC | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 7.01.181 Permanently Implanted Prostatic Devices for Benign ProstaticPayerPolicy · PREMERA-7-01-181-PERMANENTLY-IMPLANTED-PROSTATIC-DEVICES-FOR-BENIGN-0827BEC41D | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 2.04.521 (effective November 6, 2026) Evaluation of CerebrospinalPayerPolicy · PREMERA-2-04-521-EFFECTIVE-NOVEMBER-6-2026-EVALUATION-OF-CEREBROSPIN-1184F6D99F | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 2.01.106 (effective November 6, 2026) Percutaneous ElectricalPayerPolicy · PREMERA-2-01-106-EFFECTIVE-NOVEMBER-6-2026-PERCUTANEOUS-ELECTRICAL-EE19E9074C | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 9.02.501 (effective September 4, 2026) Orthognathic SurgeryPayerPolicy · PREMERA-9-02-501-EFFECTIVE-SEPTEMBER-4-2026-ORTHOGNATHIC-SURGERY-53E2FE19FD | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 3.03.06 Immersive Virtual Reality Therapy for Chronic Lower BackPayerPolicy · PREMERA-3-03-06-IMMERSIVE-VIRTUAL-REALITY-THERAPY-FOR-CHRONIC-LOWER-5C3E75F08B | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 7.01.600 Abdominal Wall Hernia Repair in AdultsPayerPolicy · PREMERA-7-01-600-ABDOMINAL-WALL-HERNIA-REPAIR-IN-ADULTS-C54AD83445 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 7.01.557 Gender Transition/Affirmation Surgery and Related ServicesPayerPolicy · PREMERA-7-01-557-GENDER-TRANSITION-AFFIRMATION-SURGERY-AND-RELATED-S-4A2336BE05 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.644 Medical Pharmacologic Treatment of Multiple SclerosisPayerPolicy · PREMERA-5-01-644-MEDICAL-PHARMACOLOGIC-TREATMENT-OF-MULTIPLE-SCLEROS-171A011C14 | New policy |
|---|
| Aug 2, 2026 | Premera Blue Cross | 5.01.626 Amyloid Antibodies for the Treatment of Alzheimer'sPayerPolicy · PREMERA-5-01-626-AMYLOID-ANTIBODIES-FOR-THE-TREATMENT-OF-ALZHEIMER-S-57D42B3A55 | New policy |
|---|